Published in Lancet on October 16, 1999
Relationship between mutations in dihydropteroate synthase of Pneumocystis carinii f. sp. hominis isolates in Japan and resistance to sulfonamide therapy. J Clin Microbiol (2000) 1.12
Mutations in the Pneumocystis jirovecii DHPS gene confer cross-resistance to sulfa drugs. Antimicrob Agents Chemother (2005) 1.04
Highly active anti-Pneumocystis carinii compounds in a library of novel piperazine-linked bisbenzamidines and related compounds. Antimicrob Agents Chemother (2004) 0.99
Pneumocystis jirovecii dihydropteroate synthase genotypes in immunocompetent infants and immunosuppressed adults, Amiens, France. Emerg Infect Dis (2004) 0.97
Multilocus microsatellite genotyping array for investigation of genetic epidemiology of Pneumocystis jirovecii. J Clin Microbiol (2014) 0.83
Polyamine transport as a target for treatment of Pneumocystis pneumonia. Antimicrob Agents Chemother (2009) 0.79
Prophylaxis of Pneumocystis carinii pneumonia: too much of a good thing? Thorax (2000) 0.78
A Case of Pneumonia Caused by Pneumocystis jirovecii Resistant to Trimethoprim-Sulfamethoxazole. Korean J Parasitol (2015) 0.75